| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Blood clot | 2 | 0 | |
| Prevent blood clotting | 2 | 1 | |
| Antiphospholipid antibody syndrome | 1 | 0 | |
| Deep vein thrombosis | 1 | 0 | |
| Factor V Leiden | 1 | 1 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Nausea | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 0 | |
| Moderate | 0 | |
| Mild | 2 | |
| None | 1 |